核酸増幅検査の世界市場レポート 2025年

核酸増幅検査の市場規模は今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は15.0%で、192億6,000万米ドルに成長します。予測期間における成長の背景には、感染症の罹患率の増加、大規模な検査能力の必要性、非公開会社からの投資の増加、迅速で正確な検査方法に対する需要の増加、高度な診断手段に対する需要の増加があります。予測期間における主な動向としては、人工知能（AI）との統合、ウェアラブルデバイスや埋め込み型デバイスの進歩、ポイントオブケア検査の採用拡大、個別化医療の拡大、デジタルヘルス技術との統合などが挙げられます。

感染症の罹患率の上昇は、今後の核酸増幅検査（NAAT）市場の成長を促進すると予想されます。感染症は、物理的接触、空気感染、汚染された食品や水、昆虫による感染など、さまざまな手段を通じて個人から個人へと直接的または間接的に広がる可能性のある生物によって引き起こされる疾患です。感染症の増加は、抗生物質耐性、気候変動、人間の行動の変化、農業慣行の変化などの要因に影響されています。核酸増幅検査（NAAT）は、感染性病原体を迅速かつ正確に検出し、迅速な診断と治療を可能にします。例えば、2023年10月、政府機関であるカナダ公衆衛生庁は、2022-2023年シーズン中に、参加州・準州がインフルエンザに関連する4,216件の入院を記録したと報告しました。その結果、感染症の発生率の増加がNAAT市場の成長に寄与しています。

核酸増幅検査（NAAT）市場の主なプレーヤーは、体外診断薬規制（IVDR）に従い、核酸増幅技術（NAT）を用いて献血された血液のサイトメガロウイルス（CMV）をスクリーニングする体外診断薬（IVD）アッセイなどの革新的なソリューションの開発に注力しています。体外診断用医薬品（IVD）とは、体外の病気や状態、感染症を検出するために、実験室で生物学的サンプルを用いて行われる検査です。例えば、2024年6月、ドイツに本拠を置くGFE社はPoET CMVを発表しました。PoET CMVは、CMV感染を迅速かつ正確に検出するために設計された体外診断用医薬品です。その特長は、高い感度と特異性であり、移植レシピエントや免疫不全患者におけるCMVの早期診断と効果的なモニタリングを可能にします。本アッセイは、信頼性の高い結果を迅速に提供し、タイムリーな臨床判断に役立つ高度な分子技術を採用しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界核酸増幅検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の核酸増幅検査市場：成長率分析
• 世界の核酸増幅検査市場の実績：規模と成長, 2019-2024
• 世界の核酸増幅検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界核酸増幅検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の核酸増幅検査市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ターゲット増幅システム
• プローブ増幅システム
• 信号増幅システム
• 世界の核酸増幅検査市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 消耗品
• 機器またはシステム
• 世界の核酸増幅検査市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応（PCR）検査
• 等温核酸増幅技術（INAAT）検査
• リガーゼ連鎖反応（LCR）テスト
• 世界の核酸増幅検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症検査
• 腫瘍学検査
• 遺伝子およびミトコンドリア疾患検査
• その他の用途
• 世界の核酸増幅検査市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断検査室
• バイオテクノロジー企業
• その他の用途
• 世界の核酸増幅検査市場ターゲット増幅システムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応（PCR）
• リアルタイムPCR（qPCR）
• 逆転写PCR（RT-PCR）
• ネストPCR
• マルチプレックスPCR
• LAMP（ループ介在等温増幅）
• 世界の核酸増幅検査市場プローブ増幅システムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 核酸配列に基づく増幅（NASBA）
• ハイブリダイゼーションに基づく増幅
• 分岐鎖増幅（BCA）
• 鎖置換増幅（SDA）
• 世界の核酸増幅検査市場信号増幅システムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酵素結合シグナル増幅
• 蛍光シグナル増幅
• 化学発光シグナル増幅
• 電気化学的信号増幅
• 磁性粒子ベースの信号増幅

第7章 地域別・国別分析

• 世界の核酸増幅検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の核酸増幅検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 核酸増幅検査市場：競合情勢
• 核酸増幅検査市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton, Dickinson and Company
• Laboratory Corporation of America Holdings
• Quest Diagnostics
• Agilent Technologies Inc.
• Grifols S.A.
• Hologic Inc.
• bioMerieux SA
• QuidelOrtho Corporation
• Bio-Rad Laboratories Inc.
• Cepheid Inc.
• GenScript Biotech Corporation
• ARUP Laboratories
• BGI Group
• Promega Corporation
• Meridian Bioscience Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 核酸増幅検査市場2029：新たな機会を提供する国
• 核酸増幅検査市場2029：新たな機会を提供するセグメント
• 核酸増幅検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Nucleic acid amplification testing (NAAT) encompasses molecular techniques designed to detect and amplify specific deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) within a sample. It is widely employed to identify pathogens at early stages of infection due to its high sensitivity. Researchers utilize NAAT to investigate gene expression, genetic variations, and disease mechanisms, which aids in understanding the bases of genetic diseases and developing targeted therapies.

The primary types of nucleic acid amplification testing include target amplification systems, probe amplification systems, and signal amplification systems. Target amplification systems are methods used to amplify specific nucleic acid sequences in a sample, crucial for improving the sensitivity and accuracy of NAAT. Product types in this field include consumables and instruments or systems featuring various technologies, such as polymerase chain reaction (PCR) tests, isothermal nucleic acid amplification technology (INAAT) tests, and ligase chain reaction (LCR) tests. NAAT is utilized in numerous applications, including infectious disease testing, oncology testing, genetic and mitochondrial disease testing, among others, and is employed by various end-users such as hospitals, diagnostic laboratories, biotechnology companies, and others.

The nucleic acid amplification testing market research report is one of a series of new reports from The Business Research Company that provides nucleic acid amplification testing market statistics, including nucleic acid amplification testing industry global market size, regional shares, competitors with a nucleic acid amplification testing market share, detailed nucleic acid amplification testing market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid amplification testing industry. This nucleic acid amplification testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nucleic acid amplification testing market size has grown rapidly in recent years. It will grow from $9.56 $ billion in 2024 to $11.03 $ billion in 2025 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to rising awareness of infectious disease diagnosis, the emergence of new pathogens, the shift towards personalized medicine, demand for point-of-care testing, regulatory approvals, and guidelines.

The nucleic acid amplification testing market size is expected to see rapid growth in the next few years. It will grow to $19.26 $ billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to the increasing incidence of infectious diseases, the need for large-scale testing capabilities, increasing investments from private companies, increasing demand for rapid and accurate testing methods, and increasing demand for advanced diagnostic measures. Major trends in the forecast period include integration with artificial intelligence (AI), advancement in wearable and implantable devices, growing adoption in point-of-care testing, expansion in personalized medicine, and integration with digital health technologies.

The rising incidence of infectious diseases is expected to drive the growth of the nucleic acid amplification testing (NAAT) market in the future. Infectious diseases are conditions caused by organisms that can spread directly or indirectly from one individual to another through various means, such as physical contact, airborne transmission, contaminated food or water, or insect-borne transmission. The rise in infectious diseases is influenced by factors like antibiotic resistance, climate change, shifts in human behavior, and changes in agricultural practices. Nucleic acid amplification testing (NAAT) quickly and accurately detects infectious pathogens, enabling prompt diagnosis and treatment, which helps in controlling the spread of diseases. For example, in October 2023, the Public Health Agency of Canada, a government agency, reported that during the 2022-2023 season, participating provinces and territories documented 4,216 hospitalizations related to influenza. As a result, the increasing incidence of infectious diseases is contributing to the growth of the NAAT market.

Key players in the nucleic acid amplification testing (NAAT) market are focusing on developing innovative solutions, such as in vitro diagnostics (IVD) assays, to screen donated blood for cytomegalovirus (CMV) using nucleic acid amplification technology (NAT) in accordance with the In Vitro Diagnostic Regulation (IVDR). An IVD assay is a test conducted on biological samples in a laboratory to detect diseases, conditions, or infections outside the body. For example, in June 2024, GFE, a Germany-based company, introduced the PoET CMV. PoET CMV is an IVD assay designed for the rapid and accurate detection of CMV infections. Its standout features include high sensitivity and specificity, enabling early diagnosis and effective monitoring of CMV in transplant recipients and immunocompromised individuals. The assay employs advanced molecular techniques to provide reliable results quickly, aiding in timely clinical decision-making.

In July 2024, Roche Holding AG acquired LumiraDx for an undisclosed amount. This acquisition allows Roche to expand its diagnostics portfolio and offer a wider range of immunoassay and clinical chemistry tests. LumiraDx, a UK-based provider of nucleic acid amplification testing, will enhance Roche's capabilities in providing thorough, high-value testing without the need for specialized cold storage. This makes it suitable for diverse healthcare settings and improves testing efficiency and patient outcomes, especially in primary care and underserved areas.

Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation

North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nucleic acid amplification testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nucleic acid amplification testing (NAAT) market consists of revenue earned by entities by provide services such as genetic disorder screening, environmental testing, infectious disease diagnosis, and pharmacogenomics. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid amplification testing (NAAT) market also includes sales of reagents, pre-packaged kits, test tubes, pipettes, and plates. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nucleic Acid Amplification Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nucleic acid amplification testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nucleic acid amplification testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nucleic acid amplification testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Target Amplification Systems; Probe Amplification Systems; Signal Amplification Systems
• 2) By Product Type: Consumables; Instruments Or Systems
• 3) By Technology: Polymerase Chain Reaction (PCR) Tests; Isothermal Nucleic Acid Amplification Technology (INAAT) Tests; Ligase Chain Reaction (LCR) Tests
• 4) By Application: Infectious Disease Testing; Oncology Testing; Genetic And Mitochondrial Disease Testing; Other Applications
• 5) By End-Use: Hospitals; Diagnostic Laboratories; Biotechnology Companies; Other End-Users
• Subsegments:
• 1) By Target Amplification Systems: Polymerase Chain Reaction (PCR); Real-Time PCR (qPCR); Reverse Transcription PCR (RT-PCR); Nested PCR; Multiplex PCR; LAMP (Loop-Mediated Isothermal Amplification);
• 2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA); Hybridization-Based Amplification; Branch Chain Amplification (BCA); Strand Displacement Amplification (SDA);
• 3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification; Fluorescent Signal Amplification; Chemiluminescent Signal Amplification; Electrochemical Signal Amplification; Magnetic Particle-Based Signal Amplification
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Siemens Healthineers
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nucleic Acid Amplification Testing Market Characteristics

3. Nucleic Acid Amplification Testing Market Trends And Strategies

4. Nucleic Acid Amplification Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Nucleic Acid Amplification Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nucleic Acid Amplification Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nucleic Acid Amplification Testing Market Growth Rate Analysis
• 5.4. Global Nucleic Acid Amplification Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nucleic Acid Amplification Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nucleic Acid Amplification Testing Total Addressable Market (TAM)

6. Nucleic Acid Amplification Testing Market Segmentation

• 6.1. Global Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Target Amplification Systems
• Probe Amplification Systems
• Signal Amplification Systems
• 6.2. Global Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Instruments Or Systems
• 6.3. Global Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR) Tests
• Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
• Ligase Chain Reaction (LCR) Tests
• 6.4. Global Nucleic Acid Amplification Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease Testing
• Oncology Testing
• Genetic And Mitochondrial Disease Testing
• Other Applications
• 6.5. Global Nucleic Acid Amplification Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Biotechnology Companies
• Other End-Uses
• 6.6. Global Nucleic Acid Amplification Testing Market, Sub-Segmentation Of Target Amplification Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR)
• Real-Time PCR (qPCR)
• Reverse Transcription PCR (RT-PCR)
• Nested PCR
• Multiplex PCR
• LAMP (Loop-Mediated Isothermal Amplification)
• 6.7. Global Nucleic Acid Amplification Testing Market, Sub-Segmentation Of Probe Amplification Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nucleic Acid Sequence-Based Amplification (NASBA)
• Hybridization-Based Amplification
• Branch Chain Amplification (BCA)
• Strand Displacement Amplification (SDA)
• 6.8. Global Nucleic Acid Amplification Testing Market, Sub-Segmentation Of Signal Amplification Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Signal Amplification
• Fluorescent Signal Amplification
• Chemiluminescent Signal Amplification
• Electrochemical Signal Amplification
• Magnetic Particle-Based Signal Amplification

7. Nucleic Acid Amplification Testing Market Regional And Country Analysis

• 7.1. Global Nucleic Acid Amplification Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nucleic Acid Amplification Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nucleic Acid Amplification Testing Market

• 8.1. Asia-Pacific Nucleic Acid Amplification Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nucleic Acid Amplification Testing Market

• 9.1. China Nucleic Acid Amplification Testing Market Overview
• 9.2. China Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nucleic Acid Amplification Testing Market

• 10.1. India Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nucleic Acid Amplification Testing Market

• 11.1. Japan Nucleic Acid Amplification Testing Market Overview
• 11.2. Japan Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nucleic Acid Amplification Testing Market

• 12.1. Australia Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nucleic Acid Amplification Testing Market

• 13.1. Indonesia Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nucleic Acid Amplification Testing Market

• 14.1. South Korea Nucleic Acid Amplification Testing Market Overview
• 14.2. South Korea Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nucleic Acid Amplification Testing Market

• 15.1. Western Europe Nucleic Acid Amplification Testing Market Overview
• 15.2. Western Europe Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nucleic Acid Amplification Testing Market

• 16.1. UK Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nucleic Acid Amplification Testing Market

• 17.1. Germany Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nucleic Acid Amplification Testing Market

• 18.1. France Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nucleic Acid Amplification Testing Market

• 19.1. Italy Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nucleic Acid Amplification Testing Market

• 20.1. Spain Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nucleic Acid Amplification Testing Market

• 21.1. Eastern Europe Nucleic Acid Amplification Testing Market Overview
• 21.2. Eastern Europe Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nucleic Acid Amplification Testing Market

• 22.1. Russia Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nucleic Acid Amplification Testing Market

• 23.1. North America Nucleic Acid Amplification Testing Market Overview
• 23.2. North America Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nucleic Acid Amplification Testing Market

• 24.1. USA Nucleic Acid Amplification Testing Market Overview
• 24.2. USA Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nucleic Acid Amplification Testing Market

• 25.1. Canada Nucleic Acid Amplification Testing Market Overview
• 25.2. Canada Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nucleic Acid Amplification Testing Market

• 26.1. South America Nucleic Acid Amplification Testing Market Overview
• 26.2. South America Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nucleic Acid Amplification Testing Market

• 27.1. Brazil Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nucleic Acid Amplification Testing Market

• 28.1. Middle East Nucleic Acid Amplification Testing Market Overview
• 28.2. Middle East Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nucleic Acid Amplification Testing Market

• 29.1. Africa Nucleic Acid Amplification Testing Market Overview
• 29.2. Africa Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Nucleic Acid Amplification Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nucleic Acid Amplification Testing Market Competitive Landscape And Company Profiles

• 30.1. Nucleic Acid Amplification Testing Market Competitive Landscape
• 30.2. Nucleic Acid Amplification Testing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Nucleic Acid Amplification Testing Market Other Major And Innovative Companies

• 31.1. Becton, Dickinson and Company
• 31.2. Laboratory Corporation of America Holdings
• 31.3. Quest Diagnostics
• 31.4. Agilent Technologies Inc.
• 31.5. Grifols S.A.
• 31.6. Hologic Inc.
• 31.7. bioMerieux SA
• 31.8. QuidelOrtho Corporation
• 31.9. Bio-Rad Laboratories Inc.
• 31.10. Cepheid Inc.
• 31.11. GenScript Biotech Corporation
• 31.12. ARUP Laboratories
• 31.13. BGI Group
• 31.14. Promega Corporation
• 31.15. Meridian Bioscience Inc.

32. Global Nucleic Acid Amplification Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nucleic Acid Amplification Testing Market

34. Recent Developments In The Nucleic Acid Amplification Testing Market

35. Nucleic Acid Amplification Testing Market High Potential Countries, Segments and Strategies

• 35.1 Nucleic Acid Amplification Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Nucleic Acid Amplification Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Nucleic Acid Amplification Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer